Valuation: Terumo Corporation

Market Cap 3,646B 23.01B 19.73B 18.43B 16.91B 31.79B 2,199B 32.32B 217B 85.15B 1,103B 86.38B 84.5B P/E 2027 *
19.3x
P/E 2028 * 19.1x
Enterprise Value 3,712B 23.42B 20.09B 18.76B 17.21B 32.37B 2,239B 32.9B 221B 86.68B 1,123B 87.94B 86.02B EV / Sales 2027 *
2.96x
EV / Sales 2028 * 2.72x
Free-Float
97.07%
Yield 2027 *
1.51%
Yield 2028 * 1.65%
1 day+4.23%
1 week-1.68%
Current month+10.86%
1 month+15.00%
3 months+9.99%
6 months+31.32%
Current year+13.50%
1 week 2,404
Extreme 2404
2,689
1 month 2,133
Extreme 2133
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,786
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.23%-1.68%-6.80%+25.10% 23.01B
+1.55%+3.17%-12.82%+10.34% 198B
+2.22%+3.71%+4.71%+15.47% 120B
+0.31%+0.93%+7.60%+75.78% 60.51B
-0.69%-4.97%+30.57%+60.51% 53.64B
+3.78%+2.19%-5.27%-31.46% 51.1B
+0.31%-1.01%+11.10%-15.25% 33.92B
-0.62%-4.48% - - 29.75B
+1.79%+0.14%+42.84%-9.02% 24.83B
+1.95%+0.13%-4.33%+5.82% 23.1B
Average +1.05%-0.50%+7.51%+15.25% 61.83B
Weighted average by Cap. +0.46%+1.27%+1.77%+17.17%

Financials

2027 *2028 *
Net sales 1,255B 7.92B 6.79B 6.34B 5.82B 10.95B 757B 11.13B 74.87B 29.32B 380B 29.74B 29.09B 1,336B 8.43B 7.23B 6.75B 6.19B 11.65B 805B 11.84B 79.64B 31.19B 404B 31.64B 30.95B
Net income 187B 1.18B 1.01B 944M 866M 1.63B 113B 1.66B 11.14B 4.36B 56.5B 4.43B 4.33B 191B 1.21B 1.03B 966M 886M 1.67B 115B 1.69B 11.4B 4.46B 57.8B 4.53B 4.43B
Net Debt 65.54B 414M 355M 331M 304M 571M 39.53B 581M 3.91B 1.53B 19.82B 1.55B 1.52B -10.03B -63.29M -54.29M -50.69M -46.51M -87.46M -6.05B -88.9M -598M -234M -3.03B -238M -232M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
20/08/26 ¥2,576.50 +4.23% 6,932,000
19/08/26 ¥2,472.00 -4.11% 9,014,900
18/08/26 ¥2,578.00 -1.60% 5,733,700
17/08/26 ¥2,620.00 -1.96% 3,448,200
14/08/26 ¥2,672.50 +1.98% 5,922,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,472.00JPY
Average target price
3,110.00JPY
Spread / Average Target
+25.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock